🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A multicenter, randomized, stratified, open-label, phase IV trial among HIV...
Status
Active Not Recruiting
Location
The Byramjee Jeejeebhoy Medical Centre (BJGMC-JHU) CRS
Start Date
2023-07-19
Trial ID
NCT05118490
Treatments Being Tested
The investigators want to know if ultra-short, effective treatment for late...
Status
Active Not Recruiting
Location
Klang Hospital
Start Date
2019-08-15
Trial ID
NCT03785106
The three-month short-course treatment with isoniazid \[H\] and rifapentine...
Status
Completed
Location
San Diego County Health and Human Services Agency
Start Date
2016-03-08
Trial ID
NCT02641106
Treatments Being Tested
Objective To determine if treatment completion with a 4-month rifampin (4R)...
Status
Unknown
Location
Multiple Locations
Start Date
2024-04-20
Trial ID
NCT05021731
Treatments Being Tested
This study is a parallel, two part, open label, individually randomized, pr...
Status
Completed
Location
The Aurum Institute NPC
Start Date
2016-11
Trial ID
NCT02980016
Treatments Being Tested
The goal of this cluster-randomized controlled trial is to evaluate the eff...
Status
Recruiting
Location
Hospital Dr. Carlos Cisterna
Start Date
2025-10-27
Trial ID
NCT07086820
An open-label, randomised controlled trial comparing compliance to treatmen...
Status
Terminated
Location
Dept of Pulmonary Medicine
Start Date
2017-10-27
Trial ID
NCT03266991
Treatments Being Tested
This study is conducted to compare the safety and effectiveness of a novel ...
Status
Recruiting
Location
Denver Health and Hospital Authority
Start Date
2019-08-01
Trial ID
NCT03474029
The Options for Delivering Isoniazid-Rifapentine (3HP) for TB Prevention (3...
Status
Completed
Location
Mulago Immune Suppression Syndrome (ISS) Clinic
Start Date
2020-07-13
Trial ID
NCT03934931
A seamless, staged Phase II/III, open-label, multicenter, non-inferiority t...
Status
Recruiting
Location
National Center for Communicable Disease (NCCD)
Start Date
2026-05-08
Trial ID
NCT06568484
Treatments Being Tested